To support the mission of wellness as well as the necessary requirement for digital fluency to thrive in the current and future states of the world, Havas Health & You launched Havas Mango. The Miami-based collective aims to reimagine wellness and build experiences that help people live their best lives.
If you are not happy with the results below please do another search
50 search results for:
Recent personnel movement in the healthcare communications industry includes Havas Health & You’s appointment of Icaro Doria as Global Chief Creative Officer.
EVERSANA, a leading provider of commercial services to the life science industry, acquired HVH Precision Analytics and its predictive analytics platform.
REALITYRx added life sciences veteran Steve Nothel to the agency’s senior management ranks. Nothel joined REALITYRx as senior VP, business development.
Scenic Biotech BV announced that Dr. C. A. Oscar Izeboud was appointed as CEO, and former acting CEO and scientific co-founder Dr. Sebastian Nijman took on the role of chief scientific officer.
Arrakis Therapeutics, a biopharmaceutical company pioneering the discovery of a new class of small molecule medicines that directly target RNA, tapped Erik Spek, Ph.D., J.D., as VP, Legal and Intellectual Property.
Akcea Therapeutics Inc., a majority-owned affiliate of Ionis Pharmaceuticals Inc., made William Andrews, M.D., FACP, chief medical officer, effective immediately. Tracy Palmer Berns has joined the company as chief compliance officer, and Dr. Kia Motesharei is now senior VP, business development and corporate strategy.
CANbridge Pharmaceuticals Inc., a biopharmaceutical company developing innovative drug candidates to treat underserved medical conditions, appointed Carrie Ann Cook to the position of senior VP/global head of business development.
Arena Pharmaceuticals Inc. made changes to the company’s research and development leadership team. Dr. Preston Klassen left the company to pursue an opportunity as CEO of a San Diego-based private company. Dr. Chris Cabell, Arena’s senior VP and chief medical officer, assumed the role of executive VP, head of research and development, and chief medical officer.
Inovio appointed two experienced senior executives to lead the company’s growth in the Asia market and to advance the clinical development of its DNA vaccine INO-4800 to combat the COVID-19 pandemic.